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httpicense.Abstract Background: NIV could be beneﬁcial in selected patients with severe asthma exacerba-
tion (SAE). However, its role is still not well deﬁned.
Objective: To evaluate the efﬁcacy of NIV using proportional assist ventilation (PAV) in severe
asthma exacerbation after failure of conventional medical therapt (CMT).
Patients and Methods: Thirty patients with severe asthma exacerbation were failed to respond on
conventional medical therapy. NIV was applied via face mask as a last option before intubation and
mechanical ventilation.
Results: The mean age was 39.2 ± 9.7 with female predominance (19 females vs. 11 males). The
successful outcome was achieved in 23/30 patients (76.6%). Follow up of the mean of respiratory
distress and gasometric parameters before recruitment vs. 1 h after NIV in successful group showed
statistically signiﬁcant improvement after NIV application as follows: HR (125.4 vs. 107.4), RR
(38.2 vs. 25.4), PH (7.28 vs. 7.36), PaCO2 (55.3 vs. 42.5), PaO2 (58 vs. 87) and PEFR% Predicted
(39 vs. 64) respectively (P< 0.001 for all items).
Also, the same improvement was in PEFR, tidal volume, peak inspiratory pressure and triggered
breaths % in successful group vs. failure group.
Conclusion: NIV can relieve respiratory distress and improve gas exchange in the majority of
patients with severe asthma exacerbation who are candidate for intubation after failure of conven-
tional medical therapy.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
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Asthma is a chronic inﬂammatory disorder of the airways,
characterized by bronchial hyper-responsiveness and reversible
air-ﬂow obstruction [1]. Asthma exacerbations, range from
mild to severe. The severe form is potentially life-threatening
and associated with respiratory failure that generally requires
hospitalization [2].is. Production and hosting by Elsevier B.V.
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are cardiopulmonary arrest, signiﬁcant alteration of conscious-
ness, respiratory exhaustion, and progressive respiratory insuf-
ﬁciency including rising of carbon dioxide levels and refractory
hypoxaemia despite aggressive bronchodilator treatment [3].
The aim of mechanical ventilation is to maintain adequate
oxygenation and prevent respiratory arrest without circulatory
compromise or lung injury until response to bronchodilators
and anti-inﬂammatory therapy occurs to allow for withdrawal
of ventilatory assistance [4].
Noninvasive ventilation (NIV) has gained increasing accep-
tance as a way to avoid intubation and improve outcomes in
selected patients with acute respiratory insufﬁciency [5]. Com-
pared with conventional medical therapy, including oxygen,
NIV can reduce intensive care unit stay and lower complica-
tion and mortality rates in selected patients with chronic
obstructive pulmonary disease (COPD) exacerbations [6].
Proportional assist ventilation (PAV) is a mode of assisted
ventilation which, by applying pressure in proportion to vol-
ume (volume assist, VA) and ﬂow (ﬂow assist, FA), should
speciﬁcally reduce the inspiratory effort needed to overcome
respiratory system elastance (Ers) and resistance (Rrs), respec-
tively [7]. Thus, it should be possible to speciﬁcally reduce the
elastic and resistive work of breathing performed by the pa-
tient [8]. In principle, unloading the respiratory muscles in this
fashion should return the relationship between the inspiratory
effort and ventilatory output (i.e, volume and ﬂow) back
toward normal [9].
Preliminary data suggest that NIV could be beneﬁcial in
selected patients with severe asthma exacerbation. It is known
that it decreases the work of breathing, and enhances the efﬁ-
cacy of inhaled drugs in experimental studies of acute asthma.
The aim of this study is to evaluate the efﬁcacy of NIV
using PAV mode in patients with severe asthma exacerbation
(SAE) after failure of conventional medical therapy including
bronchodilators and corticosteroids.
Patients and methods
Patients
We recruited patients with severe asthma exacerbation admit-
ted to respiratory intensive care unit (RICU) of Assiut Univer-
sity Hospital between March 2011 and January 2012. The
following measures were done for every patient:
1. Peak expiratory ﬂow rate (PEFR): using the hand held
automatic peak ﬂow meter (asma-1, vitalograph,
Ennis, Ireland).
2. Arterial blood gases (ABGs) obtained by blood sample
from radial artery and analyzed using automated blood
gas analyzer (Rapid Lab 855, Chiron Diagnostics;
Medﬁeld, MA).
3. Respiratory rate.
4. Heart rate.
5. Blood pressure.
They met the following inclusion criteria:
1. History of asthma for at least 1 year.
2. Talk in words with inability to complete on phrases.
3. Respiratory rate > 30/min.
4. Heart rate > 120 beat/min.5. Pulse oximetry saturation [SPO2] <90% or PaO2
<60 mmHg.
6. PH < 7.35
7. PEFR< 50% predicted.
All patients in RICU received conventional medical ther-
apy (CMT) that included: repeated nebulized salbutamol in
the ﬁrst hour (2.5 mg every 20 min), nebulized ipratropium
bromide (0.25 mg) after failure of response to salbutamol,
intravenous hydrocortisone (200 mg), Theophylline was
administered intravenously 6 mg/kg over 20–30 min (if not
administered before), followed by a continuous infusion of
0.6 mg/kg/h, and intravenous magnesium sulfate (2 g over
20 min).
Exclusion criteria:
1. Hypotension.
2. Pregnancy.
3. Inability to protect airways.
4. Facial trauma or any other contraindication to NIV.
5. Pulmonary inﬁltrates suggesting pulmonary oedema,
pneumonia, or active tuberculosis.
Initiation of non invasive ventilation (NIV)
Patients were ﬁrst ﬁtted with oronasal mask (Comfort full
mask, Respironics Inc, Murrysville PA) connected to BiPAP
vision ventilator (Respironics Inc, Murrysville PA). Ventilator
was adjusted to PAV/T mode with expiratory positive airway
pressure (EPAP) to 4 cm H2O. PAV settings included volume
assist (VA), ﬂow assist (FA), and% of set that was adjusted at
80% of set VA, and FA. Settings were adjusted to obstructive
set (VA = 15 cmH2O/L; and FA= 12 cm H2O/L/sec and
decrease% set if Peak pressure exceeds 20 cm H2O to prevent
gastric insufﬂation and distention.
Timed mode (T) in PAV/T mode is a time triggered pres-
sure limited, time cycled mode (pressure controlled ventila-
tion). This ensures that patients will receive a minimum
number of breaths per minute in the event that the spontane-
ous breathing rate drops below the rate setting. If the patient
fails to initiate an inspiration within the interval determined
by rate control, the unit triggers a timed breath resulting in a
pressure controlled (pressure limited, time cycled) breath at
the set IPAP level. The duration of each timed breath is con-
trolled by an inspiratory time control.
FiO2 was adjusted to maintain O2 saturation P90%. NIV
was applied continuously for as long as possible, and interrup-
tion of NIV was allowed only for PEFR measurement or secre-
tion clearance, and for no more than 5 min. Inhaled
bronchodilators were given via T-piece in the ventilator circuit,
without discontinuing the circuit.
Monitoring during NIV
A strict observation and monitoring through the ﬁrst hour of
NIV of the following:
(a) Continuous monitoring of Heart rate, respiratory rate,
blood pressure, and SaO2%.
(b) Arterial blood gases (ABGs) analysis.
(c) Mechanical parameters: Tidal volume (VT), minute
ventilation (VE), Peak inspiratory pressure (PIP), and
patient triggered breaths %.
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Figure 1 Follow up of RR in both groups showing a signiﬁcant
improvement of RR in successful group.
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Figure 2 Follow up of HR in both groups showing a signiﬁcant
improvement in HR in successful group.
Admission. CMT 1h NIV Discont.
7.08
7.12
7.16
7.2
7.24
7.28
7.32
7.36
7.4
7.44
7.48
7.52
Success
Failure
Figure 3 Follow up of pH in both groups showing a signiﬁcant
improvement in successful group.
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curves (pressure, volume, and ﬂow) with patient effort.
Major criteria for intubation were
(a) Respiratory arrest, (b) Haemodynamic instability with sys-
tolic pressure less than 70 mmHg, and a heart rate of 50 beats/
min or less, and (c) Coma.
Minor criteria of intubation were
(a) A respiratory rate more than 35 breaths/minutes and higher
than the value recorded on admission, (b) An arterial
pH 6 7.30 and lower than the value recorded on admission,
(c) A PaO2/FiO2 less than 200 despite oxygen supplementa-
tion, and (d) Deterioration of one or more points of the
neurological scale of Kelly and Matthay [10].
Follow up of these parameters at 6 h and before discontin-
uation of NIV was done. Through this period of observation,
the presence of one major criterion at any time or two minor
criteria at the end of 1 h NIV was considered to indicate the
need for intubation [11].
Outcome measures
Successful treatment was deﬁned as objective improvement
during NIV, included the following changes from spontaneous
breathing: (1) pH > 7.35, (2) SaO2P 90%, (3) A decrease of
P20% in respiratory rate compared with spontaneous breath-
ing, and (4) Normal sensory state. Subjective criteria included
improvement of dyspnea and the patient’s comfort [12].
Failure is deﬁned as the patients’ need for intubation by fulﬁll-
ment one major criterion at any time or two minor criteria
after 1 h NIV.
Discontinuation of NIV
Discontinuation of NIV For successfully treated patients if
clinical stability had been achieved [6]. Clinical stability was
deﬁned as: Reduction in respiratory rate to less than
24 breath/min; heart rate of less than 110/min; a compensated
pH > 7.35; and adequate oxygenation >90% O2 saturation
with FiO2 not more than 35%. When NIV was discontinued,
oxygen was administered via venturi mask at the previous
FiO2 (before discontinuation).
Statistical analysis
Statistical analysis was performed using Statistical package for
the Social Sciences (SPSS-version 16). Results were given as
the mean ± SD for numerical data and as frequency using
chi-square test for nominal data. Success and failure were com-
pared by using unpaired Student’s t-test. Paired Student’s
t-test was used to compare CMT vs. admission, 1 h NIV vs.
CMT, and before discontinuation of NIV vs. 1 h NIV. Differ-
ences were considered signiﬁcant when P value <0.05.
Results
Gender distribution revealed female predominance (19 females
Vs 11 males) in the studied asthmatic patients. The successful
outcome was achieved in 23/30 patients (76.6%).
Fig. 1 shows follow up of respiratory rate (RR) in both
groups. A signiﬁcant (P< 0.001) reduction of RR in success-
ful group (from 38.2 ± 3.3 on conventional therapy to
25.4 ± 2.7 after 1 h NIV) with more improvement beforediscontinuation from NIV. On the other hand, no signiﬁcant
change was observed in failure group. Also follow up of heart
rate (HR) demonstrated the same results with a signiﬁcant
(P< 0.001) reduction of HR in successful group (from
125.3 ± 9.3 on conventional therapy to 107.4 ± 5.3 after 1 h
NIV) with more improvement before discontinuation from
NIV. Also, there was no signiﬁcant change observed in failure
group in this parameter as in Fig. 2.
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Figure 4 Follow up of PaCO2 in both groups showing a
signiﬁcant improvement in PaCO2 in successful group
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Figure 5 Follow up of PaO2 in both groups showing a
signiﬁcant improvement of PaO2 in successful group.
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Figure 6 Follow up of PEFR in both groups showing a
signiﬁcant increase of PEFR% predicted in successful group with
no signiﬁcant change in failure group.
Table 1 Ventilatory parameters after 1 h ventilation.
Ventilatory variable Success (23)
Mean ± SD
Failure (7)
Mean ± SD
P value
VT, ml 311.2 ± 32.1 197.4 ± 13.5 <0.001
Peak inspiratory
pressure, CmH2O
14.4 ± 1.9 11.6 ± 1.5 <0.01
Patient triggered breaths % 89.2 ± 3.6 76.1 ± 3.7 <0.001
Table 2 Duration of ventilation and ICU stay in successful
group.
Variables Successful group (23)
Duration of ventilation (hours)
mean ± SD
22.8 ± 10.1
ICU stay (hours) mean ± SD 36.2 ± 7.1
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signiﬁcant (P< 0.01) improvement of pH, PaCO2 and PaO2
was observed in successful group after 1 h NIV. In failure
group, only PaO2 was increased after 1 h NIV but its values
(64.4 ± 4.9 mmHg) were signiﬁcantly lower than successful
group (87 ± 5.9 mmHg).
Fig. 6 shows a signiﬁcant (P< 0.01) increase of PEFR%
predicted in successful group (from 39 ± 7.4 on conventional
medical therapy to 64 ± 6.1 after 1 h NIV) with no signiﬁcant
change in failure group. There were signiﬁcant lower values of
PEFR in failure group after conventional treatment (23 ± 4.5)
vs. (39 ± 7.4) in successful group.
Table 1 shows the mechanical parameters after 1h NIV.
There were a signiﬁcantly (P< 0.01) higher tidal volume, peakpressure and triggered breaths % in successful group versus
failure group.
Table 2 shows the duration of ventilation and ICU stay in
successful group.
Discussion
A signiﬁcant number of asthmatics experience life-threatening
attacks culminating in intensive care unit admission. Conven-
tional medical therapy includes high dose systemic corticoste-
roids and inhaled bronchodilators. Patients with especially
severe attacks may develop respiratory failure and need endo-
tracheal intubation and mechanical ventilation [13].
Compared with conventional therapy, including oxygen,
NIV can reduce intensive care unit stay and lower complica-
tion and mortality rates in selected patients with chronic
obstructive pulmonary disease (COPD) exacerbations [6].
Even though non-invasive ventilation (NIV) has been shown
to be effective in a wide variety of clinical settings, reports
on NIV in asthmatic patients are scarce. According to a few
prospective clinical trials reporting promising results in favor
of the use of NIV in a severe asthma attack, a trial of NIV
prior to invasive mechanical ventilation seems acceptable and
may beneﬁt patients by decreasing the need for intubation
and by supporting pharmacological treatments [14].
The pathophysiologic condition of acute respiratory failure
in asthma is in many ways similar to that of acute respiratory
failure in COPD. Therefore, there is a reason to believe that
NIV could also be successful in patients with severe acute asth-
ma [15].
The successful outcome in all 30 patients who failed to re-
spond on CMT was achieved in 23 patients (76.6%) that are
comparable with the results from other studies on NIV in
acute severe asthma [16–18].
In our study, Indices of respiratory distress (HR, and RR)
failed to improve after CMT. On the other hand, the ﬁrst hour
NIV revealed signiﬁcant decrease of HR (from 125.3 ± 9.3 to
107.4 ± 5.3) and RR (from 38.2 ± 3.3 to 25.4 ± 2.7) in
responding patients. This is consistent with a recent study
[18] on Children with severe asthma unresponsive to conven-
tional therapy with marked increased work of breathing. They
described that after 1 h NIV, HR fell by 13.5 ± 14 beats/min,
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ducted on adults with severe asthma revealed signiﬁcant de-
crease of HR and RR after the ﬁrst hour of NIV [2,19,20].
As regard to gasometric changes, our results demonstrated a
signiﬁcant improvement of pH, PaCO2 and PaO2 in successful
group after 1 h ventilation. Meduri et al., described a series of
17 asthmatic patients treated with NIV. Their main ﬁnding
was that NIV improved gas exchange in status asthmaticus.
A statistically signiﬁcant reduction in PaCO2 was observed. A
concomitant improvement in oxygenation was also observed,
with an increase in PaO2/FiO2 from 315 ± 41 to 403 ± 47
mmHg [16]. Fernandez et al., reported in a retrospective obser-
vational analysis of 33 patients with acute asthmatic attack that
22 patients received NIV, and were compared to a group of 11
patients treated with invasive mechanical ventilation. On
initiation of invasive and noninvasive ventilation, PaCO2 and
PaO2 decreased similarly in both groups [17]. On the other hand
Gupta et al., reported that there was a signiﬁcant improvement
in PaO2 but not pH or PaCO2 in NIV group [2].
Measurement of lung functions in our study demonstrated
that PEFR% predicted signiﬁcantly increased in successful
group (from 39 ± 7.4% on conventional medical therapy to
64 ± 6.1% after 1 h NIV) i.e, 64% increase (>50% improve-
ment). On the other hand, in the failure group FEFR increased
only 30%. This is consistent with Soroksky et al., who demon-
strated that 80% of the patients in the BiPAP group reached
the predetermined primary end-points (an increase of at least
50% in FEV1 compared with baseline) versus 20% of control
patients [21]. A more recent report by Soma et al., has found
similar results with the mean percent change in FEV1 signiﬁ-
cantly improved after 40 min in the high-pressure group
compared with that in the control group [20]. On the other
hand, Gupta et al reported that, the number of patients who
had >50% improvement in FEV1 at 1 h NIV was non-signif-
icantly greater in the NIV arm vs. CMT [2].
As regard to the mechanical parameters after 1h NIV in our
study, there were signiﬁcantly (P< 0.01) higher tidal volume,
peak pressure and triggered breaths % in successful group ver-
sus failure group. The use of PAV/T mode added this advan-
tage as the level of pressure support is proportional to
patient effort, thus peak inspiratory pressure is higher in suc-
cessful outcome with better effort and tidal volume. Soma
et al., concluded that higher inﬂation pressure (14 cmH2O)
on NIV led to clinical improvement in patients with acute asth-
ma attacks and this is consistent with our results
(14.4 ± 1.9 cmH2O is the mean value of inspiratory pressure
in successful group) [20]. Also patient triggered breaths %
after 1 h NIV is near 90% from total breaths in successful out-
come patients, thus it is considered an important parameter to
predict success on NIV.
Finally NIV in our study could decrease the rate of intuba-
tion and save more than 75% of patient from hazards of inva-
sive ventilation with short duration on NIV and short ICU
stay. In a recent study, the need for intubation in patients with
severe attacks of asthma was decreased after introduction of
NIV [19]. Also in a study of NIV in pediatric status asthmaticus,
only ﬁve from seventy two patients required intubation [18].
Conclusions
NIV can relieve respiratory distress and improve gas exchange
in the majority of patients with severe asthma exacerbationwho are candidate for intubation after failure of conventional
medical therapy.References
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